A site is ready when six domains clear at once: research team, infrastructure, study management, data and systems, quality oversight, and ethics and safety. Three items gate activation regardless of protocol: verified system access to EDC and IWRS, a signed delegation and training record, and confirmed investigational product and pharmacy readiness. FDA guidance and ICH GCP anchor the documentation standard; an operational partner like Haiphai can help close gaps faster when timelines are tight.
TL;DR:
- Most sites face delays primarily due to contracting and IRB approval cycles, which can be shortened by starting negotiations and submissions simultaneously.
- Ensuring pharmacy and investigational product readiness requires verifying temperature logs, contingency plans, accountability logs, and lab procedures before schedule SIV.
- Achieving site readiness hinges on confirming system accesses, current delegation and training logs, and finalized ethics approvals, with timely documentation crucial for successful activation.
- Embedding operational expertise with governed AI helps coordinate the six readiness domains, reducing disjointed workflows and reclaiming valuable startup time.
- The final pre-SIV checklist must confirm functional system access, current delegation and training records, and complete pharmacy and document readiness, with any missing item pushing back activation.
Table of Contents
- The Site Readiness Checklist, Domain by Domain
- What Does Research Team Readiness Actually Require?
- Is the Pharmacy and Investigational Product Setup Ready?
- Why Do Contracts and Budgets Slow Down Every Trial?
- Are Your Systems and Data Flows Actually Working?
- What Quality Oversight Has to Be in Place?
- What Ethics and Safety Documents Must Be Finalized?
- What Should the Final Pre-SIV Runbook Look Like?
- Where Do Most Sites Actually Get Stuck?
- Why Embedding Operational Expertise Shortens Activation
- Get Your Site Activation Timeline Back Under Control
- Sources
- FAQ
The Site Readiness Checklist, Domain by Domain
A published framework built from 217 trial site qualifications organizes readiness into six domains and 40 underlying practices. Use it as a pre-activation gate check, with an owner and a due date assigned to each line.
- Research team: signed CVs, licenses, and a complete delegation log filed in the ISF.
- Infrastructure: calibrated equipment with current certificates, stored in the site file.
- Study management: an executed clinical trial agreement (CTA) and finalized budget.
- Data and systems: confirmed EDC and IWRS access for every delegated role.
- Quality oversight: a documented, risk-based monitoring plan with named contacts.
- Ethics and safety: final IRB approval on file, with the approval letter itself, not just the confirmation email.
Timestamp every checked item. When a monitor or auditor asks "when was this verified," a checklist without dates is functionally useless.
What Does Research Team Readiness Actually Require?
Investigator oversight is not a formality. FDA guidance on investigator responsibilities singles out delegation to inadequately qualified staff as a recurring inspection finding, and the fix is procedural, not conceptual: a signed delegation-of-authority log tied to Form 1572, listing each task, the person responsible, the date assigned, and their supporting qualifications.
Training has the same paper trail requirement. FDA also specifies that sponsor training, or documented equivalent site training, must exist for every delegated staff member, including anyone who joins mid-study as a replacement. Build a simple training matrix and pair it with an SOP that triggers automatically when staff turn over.
- Maintain one delegation log per protocol, updated the day a role changes.
- Store completed training certificates alongside the matrix, not in a separate folder.
- Document the PI's supervision plan: how often they meet with staff, how they review monitor findings, and how corrective actions get closed out.
Pro Tip: Review the delegation log at every monitoring visit, not just at SIV. A stale log is one of the fastest ways to turn a routine visit into a finding.
Is the Pharmacy and Investigational Product Setup Ready?
IP and pharmacy issues stall more activations than most operations leads expect, mostly because they involve a third department that clinical operations doesn't directly manage. Verify each of these before scheduling SIV:
- Temperature logs and calibration certificates for every storage unit holding investigational product.
- A written alarm response plan and confirmed contingency power for excursions.
- Completed PAB or Pharmacist of Record training documentation, plus current IP accountability logs.
- Quarantine procedures for damaged, expired, or recalled product.
- Lab manual review sign-off, current instrument calibration, and executed specimen shipping agreements.
A single missing temperature log can hold an entire site's activation, even when every other domain is complete.
Why Do Contracts and Budgets Slow Down Every Trial?
Contract and budget negotiation is the most common bottleneck in study start-up, largely because it routes through institutional legal and finance offices that run on their own timeline, disconnected from the regulatory track. Treating it as an afterthought instead of a managed parallel workstream is the single biggest self-inflicted delay in site activation.
Run contracting and budget finalization alongside regulatory and IRB work from day one, with a named owner on each side and a defined escalation path to institutional signatories when a draft stalls.
- Confirm the CTA is executed, not just "in final review."
- Lock per-subject costs and any institutional overhead addenda before SIV scheduling.
- Escalate stalled drafts to a named signatory after a set number of business days, not indefinitely.
Pro Tip: Pre-negotiated contract templates and master agreements with repeat institutions can cut this cycle by weeks. If your organization runs multiple sites at the same academic center, push for a master CTA once and reuse it.
Are Your Systems and Data Flows Actually Working?
Confirm role-based logins for EDC, IWRS or IVRS, lab portals, and sponsor safety portals, then run a real transaction through each one before SIV, not just a login test. A password that works but a form that won't save is a common surprise on day one of enrollment.
For any decentralized elements, FDA's draft DCT guidance requires documenting the origin of each data point and maintaining a task log for local health care providers performing trial-related duties at a distance from the primary site. Build a simple data flow diagram showing where each data type originates and how it reaches the TMF.
- Test critical EDC workflows end-to-end, including query resolution.
- Confirm IWRS randomization and drug-dispensing logic with a dry run.
- File a data flow diagram for decentralized visits in the ISF.
- Verify the TMF holds every essential document required for inspection, accessible on demand.
What Quality Oversight Has to Be in Place?
A risk-based monitoring plan needs a defined schedule and named monitoring contacts before the first subject enrolls, not drafted reactively after the first visit. Pair it with key risk indicators and key performance indicators that carry explicit thresholds and a documented escalation workflow, so a missed metric triggers action rather than getting noticed weeks later.
- Confirm the monitoring plan and schedule are signed and filed.
- Set KRI and KPI thresholds with an owner responsible for tracking each one.
- Document SOPs for query resolution, source-data verification, and CAPA closure.
A risk register with linked KRIs gives quality teams a single place to track this instead of scattering it across spreadsheets and email threads.
What Ethics and Safety Documents Must Be Finalized?
Final IRB approval, the letter itself along with a record of any related correspondence, has to sit in the ISF before enrollment starts. Sites participating in multi-site studies need their single IRB reliance plan documented as well.
- Signed, site-adapted informed consent forms, filed and version-controlled.
- A safety monitoring plan naming the local pathway for urgent participant care.
- A documented, tested process for SAE reporting timelines and responsible parties.
Every one of these needs a named person who confirms it, not just a checkbox.
What Should the Final Pre-SIV Runbook Look Like?
The SIV functions as the last activation checkpoint, and treating it as anything less invites incomplete activation. Practitioner guidance is blunt about the fix: if a gating item isn't done, postpone.
- Confirm EDC and IWRS access works for every delegated role, tested that week.
- Verify the delegation log is current and every signature is dated.
- Confirm all required training sign-offs are filed, including any recent hires.
- Verify IP storage, temperature logs, and pharmacy accountability records are complete.
- Confirm the TMF and ISF hold every essential document, with nothing pending.
Assign one SIV coordinator to collect timestamped confirmation from each domain owner before the monitor arrives.
Pro Tip: If even one item on this list is incomplete, move the SIV date. An incomplete activation on record is far harder to explain during an inspection than a two-week delay.
Where Do Most Sites Actually Get Stuck?
Contracts and IRB cycles cause most delays, and both are avoidable with better process design rather than more staff.
- Run contract and budget negotiation in parallel with regulatory work, with SLAs and a clear escalation path.
- Avoid incomplete IRB submissions by running an internal pre-review checklist before anything goes to the board; resubmission cycles routinely add three to four weeks.
- Request sponsor system provisioning deadlines early, and test EDC and IWRS credentials the moment they arrive rather than waiting for SIV week.
Pro Tip: Most activation delays trace back to a workstream that started late, not one that moved slowly. Start contracting and IRB submission on the same day you finalize the protocol synopsis.
Why Embedding Operational Expertise Shortens Activation
Most site activation delays aren't caused by any single missing document. They come from six domains running on six disconnected timelines with no one accountable for how they intersect. That's a coordination problem, not a compliance problem, and it's why checklists alone rarely fix it.
Haiphai's model embeds senior operational teams directly into a client's workflows, using governed AI to track delegation, training, contracting, and systems readiness across all six domains at once instead of in sequence. That coordination is where clients report reclaiming a significant amount of operational time on the path to approval. An outside operational partnership makes the most sense for complex protocols, multi-site programs, or trials with decentralized elements, where the coordination burden outpaces what an internal team can track manually.
— John
Get Your Site Activation Timeline Back Under Control
Haiphai isn't a checklist template or another portal to log into. It's an operational partnership that embeds directly into your team to find where activation is actually stalling, whether that's contracting, training documentation, or systems provisioning, and fixes the workflow itself.
The AI Velocity Diagnostic maps your specific bottlenecks before you commit to a fix, and the clinical and regulatory operations solutions cover delegation tracking, training automation, and site activation workflows across all six readiness domains. Clients working with Haiphai report reclaiming a significant amount of operational time on their path to approval, time that matters directly to valuation and funding runway. If your team is juggling multiple sites or a decentralized protocol and the coordination load feels unmanageable internally, start with a diagnostic conversation about where your specific activation bottlenecks live.
Sources
- Guidance for Industry: Investigator Responsibilities
- A framework for assessing clinical trial site readiness
- Study start-up: Clinical trial start-up guide
FAQ
What Is a Site Readiness Checklist?
It's a domain-organized list of the documents, system access, and staff qualifications a clinical trial site needs verified before it can open and enroll participants, typically covering research team, infrastructure, study management, data and systems, quality oversight, and ethics and safety.
What Are the Three Gating Items Before SIV?
Verified EDC and IWRS system access, a signed and current delegation and training log, and confirmed investigational product and pharmacy readiness. Practitioner guidance recommends postponing SIV if any of these three are incomplete.
What Causes the Most Site Activation Delays?
Contract and budget negotiation is the most frequently cited bottleneck in study start-up, followed closely by IRB resubmission cycles caused by incomplete initial submissions.
Does HaiPhai Help With Site Activation Readiness?
Yes. Haiphai embeds operational teams and governed AI directly into a site or sponsor's workflows to coordinate delegation, training, contracting, and systems readiness, and current pricing for engagements is available on the Haiphai services page.
What Documents Must Be in the TMF Before Enrollment?
The trial master file needs the executed CTA, final IRB approval letter, current delegation log, training records, and system access confirmations filed and accessible before the first participant enrolls.